Drugs and Devices

Hospira widens recall of Liposyn and propofol

Hospira has widened its March 31 recall of Liposyn and propofol to include more lots. The recall was issued because some containers may contain particulate matter. Read more at http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm215033.htm.

Related Articles:

Leave a Reply

You have to agree to the comment policy.